Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adil Javed

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Investigation into the Antihypertensive Effects of Diosmetin and Its Underlying Vascular Mechanisms Using Rat ModelTaseer Ahmad, Adil Javed, Taous Khan, et al.
Multiple Sclerosis and Related Disorders|February 11, 2023
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective studyAmanda Frisosky Abuaf, Adil Javed, Samuel R Bunting, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|May 15, 2012
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis opticaRebecca S Romero, Ismael Gutierrez, Eugene Wang, et al.
Plos One|December 22, 2018
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatmentFredrika Koskimäki, Jacqueline Bernard, Jeong Yong, et al.
Neuroradiology|June 16, 2024
T1 mapping from routine 3D T1-weighted inversion recovery sequences in clinical practice: comparison against reference inversion recovery fast field echo T1 scans and feasibility in multiple sclerosisGriffin Young, Vivian S Nguyen, Quentin Howlett-Prieto, et al.
The Lancet. Neurology|January 22, 2008
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinicianAaron Boster, Gilles Edan, Elliott Frohman, et al.
3 Biotech|October 16, 2020
Mechanisms underlying the wound healing and tissue regeneration properties of <i>Chenopodium album</i>Ali Said, Naveera Naeem, Sami Siraj, et al.
Journal of Pharmacy & Bioallied Sciences|August 4, 2020
<i>In vitro</i> cytotoxic and antimicrobial activities of <i>Erythrina suberosa</i> (Roxb) barkZubair Ahmed, Sohail Aziz, Syed Alauddin, et al.
Journal of the Neurological Sciences|November 1, 2011
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosisXuan Feng, Nicholas P Reder, Mounica Yanamandala, et al.
Plos One|January 9, 2018
Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseasesAnza B Memon, Adil Javed, Christina Caon, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Investigation into the Antihypertensive Effects of Diosmetin and Its Underlying Vascular Mechanisms Using Rat ModelTaseer Ahmad, Adil Javed, Taous Khan, et al.
Multiple Sclerosis and Related Disorders|February 11, 2023
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective studyAmanda Frisosky Abuaf, Adil Javed, Samuel R Bunting, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|May 15, 2012
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis opticaRebecca S Romero, Ismael Gutierrez, Eugene Wang, et al.
Plos One|December 22, 2018
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatmentFredrika Koskimäki, Jacqueline Bernard, Jeong Yong, et al.
Neuroradiology|June 16, 2024
T1 mapping from routine 3D T1-weighted inversion recovery sequences in clinical practice: comparison against reference inversion recovery fast field echo T1 scans and feasibility in multiple sclerosisGriffin Young, Vivian S Nguyen, Quentin Howlett-Prieto, et al.
The Lancet. Neurology|January 22, 2008
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinicianAaron Boster, Gilles Edan, Elliott Frohman, et al.
3 Biotech|October 16, 2020
Mechanisms underlying the wound healing and tissue regeneration properties of <i>Chenopodium album</i>Ali Said, Naveera Naeem, Sami Siraj, et al.
Journal of Pharmacy & Bioallied Sciences|August 4, 2020
<i>In vitro</i> cytotoxic and antimicrobial activities of <i>Erythrina suberosa</i> (Roxb) barkZubair Ahmed, Sohail Aziz, Syed Alauddin, et al.
Journal of the Neurological Sciences|November 1, 2011
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosisXuan Feng, Nicholas P Reder, Mounica Yanamandala, et al.
Plos One|January 9, 2018
Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseasesAnza B Memon, Adil Javed, Christina Caon, et al.
Pageof 4